Cancer treatment approved

The US FDA has approved Doxorubicin-HCI Liposomal Injection from Israel’s Ayana for the treatment of ovarian cancer, multiple myeloma, and Kaposi’s Sarcoma. The novel chemotherapy was developed by Hebrew University professor Yechezkel Barenholz (see here and here).

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *